AQR Capital Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.39M Buy
1,370,497
+726,300
+113% +$1.54M ﹤0.01% 2000
2025
Q4
$1.32M Sell
644,197
-43,558
-6% -$126K ﹤0.01% 2394
2025
Q3
$2.39M Sell
687,755
-79,860
-10% -$223K ﹤0.01% 1877
2025
Q2
$1.69M Sell
767,615
-253,021
-25% -$414K ﹤0.01% 1886
2025
Q1
$1.18M Sell
1,020,636
-49,517
-5% -$72.8K ﹤0.01% 1926
2024
Q4
$1.36M Buy
1,070,153
+693,956
+184% +$1.77M ﹤0.01% 1723
2024
Q3
$1.28M Buy
376,197
+330,307
+720% +$1.44M ﹤0.01% 1733
2024
Q2
$214K Buy
45,890
+24,758
+117% +$140K ﹤0.01% 2398
2024
Q1
$157K Buy
+21,132
New +$176K ﹤0.01% 2292
2023
Q4
Sell
-36,933
Closed -$288K 2355
2023
Q3
$288K Buy
36,933
+9,158
+33% +$78.5K ﹤0.01% 2020
2023
Q2
$229K Sell
27,775
-28,433
-51% -$248K ﹤0.01% 2043
2023
Q1
$408K Buy
56,208
+23,446
+72% +$208K ﹤0.01% 1838
2022
Q4
$291K Buy
+32,762
New +$360K ﹤0.01% 1980
2022
Q2
Sell
-48,899
Closed -$930K 2205
2022
Q1
$930K Buy
48,899
+34,773
+246% +$646K ﹤0.01% 1579
2021
Q4
$375K Sell
14,126
-7,289
-34% -$251K ﹤0.01% 1916
2021
Q3
$880K Buy
21,415
+5,176
+32% +$284K ﹤0.01% 1618
2021
Q2
$920K Sell
16,239
-7,131
-31% -$263K ﹤0.01% 1625
2021
Q1
$982K Buy
23,370
+6,988
+43% +$398K ﹤0.01% 1557
2020
Q4
$1.15M Sell
16,382
-7,948
-33% -$327K ﹤0.01% 1442
2020
Q3
$683K Sell
24,330
-11,362
-32% -$370K ﹤0.01% 1599
2020
Q2
$1.06M Sell
35,692
-4,194
-11% -$110K ﹤0.01% 1439
2020
Q1
$791K Buy
+39,886
New +$1.01M ﹤0.01% 1432
2018
Q4
Sell
-20,014
Closed -$637K 2212
2018
Q3
$637K Buy
20,014
+4,221
+27% +$136K ﹤0.01% 1872
2018
Q2
$566K Hold
15,793
﹤0.01% 1938
2018
Q1
$524K Buy
15,793
+7,812
+98% +$278K ﹤0.01% 1895
2017
Q4
$245K Buy
+7,981
New +$201K ﹤0.01% 2106

Other funds holding EDIT